Salivary Melatonin Profile: How Training and Exercise Change Your Circadian Signal

What Is the Normal Salivary Melatonin Range?

The normal salivary melatonin range depends heavily on time of day, age, and light exposure history. Basal daytime concentrations sit below 5 pg/mL in healthy adults. DLMO, the most clinically useful marker, occurs when salivary melatonin first crosses a threshold of 3 to 4 pg/mL under dim-light conditions (<10 lux), typically 2 to 3 hours before habitual sleep onset.

Nocturnal peaks range from roughly 80 to 150 pg/mL in adults aged 20 to 50, measured between 01:00 and 03:00 local time. Values decline with age: adults over 60 may peak at only 30 to 60 pg/mL, a 50 to 60 percent reduction linked to calcification of the pineal gland and reduced sympathetic input. Waldhauser et al. Documented the age-related decline across a lifespan cohort, with the steepest drop occurring after age 40.

Why Saliva Rather Than Serum?

Saliva offers a practical advantage. Salivary melatonin reflects the unbound, bioactive fraction and correlates tightly with plasma (r approximately 0.85 to 0.96 across multiple validation studies). Serial sampling at home requires no venipuncture, which means the measurement environment can be standardized more easily, with participants resting in dim light rather than sitting under bright clinic fluorescents that would suppress the very signal being measured.

Interpreting DLMO in Practice

A DLMO before 20:30 suggests an advanced circadian phase, commonly seen in early-morning exercisers who also practice consistent sleep schedules. A DLMO after 23:30 points toward delayed circadian phase, common in late-night exercisers, shift workers, and adolescents. The Endocrine Society's clinical practice guideline on circadian rhythm sleep-wake disorders specifies DLMO as the preferred biomarker for phase assessment, superseding actigraphy alone. The 2015 Endocrine Society guideline places DLMO at the center of circadian disorder diagnosis and treatment planning.

How Aerobic Exercise Timing Shifts the Melatonin Profile

The timing of aerobic exercise acts as a non-photic zeitgeber, a time cue that resets the suprachiasmatic nucleus (SCN) independently of light. The direction and magnitude of the phase shift depend on where in the circadian cycle the stimulus falls.

Morning Aerobic Exercise (06:00 to 10:00)

Aerobic sessions completed in the early morning consistently advance the circadian clock. A controlled crossover study by Youngstedt et al. Demonstrated that 3 consecutive days of morning exercise (60 minutes at 60 percent VO2 max, 07:00 start) advanced DLMO by a mean of 42 minutes compared with sedentary controls. Youngstedt et al. Showed morning exercise produced significant circadian phase advances in a crossover design.

The advance is additive with morning bright light. Athletes who train outdoors in the first 2 hours after sunrise receive both photic and non-photic zeitgeber input, potentially producing DLMO advances of 60 to 90 minutes over a training week. This is clinically useful for jet-lagged athletes traveling eastward, where a phase advance is therapeutic.

Afternoon Aerobic Exercise (14:00 to 18:00)

Afternoon aerobic work (60 to 75 percent VO2 max) produces minimal net phase shift but tends to slightly increase total nocturnal melatonin area under the curve (AUC) compared with sedentary days, likely through exercise-induced reductions in evening cortisol that allow earlier melatonin secretion. A 2021 meta-analysis of 23 randomized controlled trials found that afternoon aerobic exercise improved subjective sleep quality scores (Pittsburgh Sleep Quality Index, mean reduction 2.6 points) and objective sleep efficiency (polysomnography, mean increase 5.3 percent), consistent with modest circadian optimization without strong phase-shifting. The meta-analysis by Xie et al. (2021) confirmed afternoon aerobic exercise benefits across sleep architecture measures.

Late Evening Aerobic Exercise (After 20:00)

This is where things get complicated. Vigorous aerobic exercise within 90 minutes of habitual sleep onset raises core body temperature, suppresses melatonin secretion acutely through sympathetic beta-adrenergic pathways, and may delay DLMO by 20 to 45 minutes. Not every individual responds identically: a 2019 systematic review of 23 studies found that light-to-moderate evening exercise (<60 percent VO2 max) did not consistently impair sleep onset or melatonin timing, while vigorous sessions (>75 percent VO2 max) produced more consistent melatonin suppression. Stutz et al. (2019) systematically reviewed exercise timing and sleep, finding intensity is a more important moderator than timing alone.

Resistance Training and the Melatonin Profile

Resistance training affects melatonin through distinct mechanisms compared with aerobic exercise. Acute heavy resistance sessions (80 to 90 percent 1-rep max, compound movements) generate higher post-exercise core temperature elevations and greater sympathetic nervous system activation than moderate aerobic sessions at matched durations.

Acute Effects of Heavy Lifting

A single heavy resistance session completed at 19:00 has been shown to suppress salivary melatonin concentrations measured at 22:00 by 15 to 30 percent compared with non-exercise control nights. The suppression is proportional to session intensity and volume: a high-volume powerlifting session (5 sets of 5 at 85 percent 1RM across 5 compound movements) suppresses melatonin more than a moderate hypertrophy session (3 sets of 10 at 70 percent 1RM). Myllymäki et al. Documented heart rate variability and hormonal disruptions following late-evening high-intensity resistance training.

Chronic Adaptation Over a Training Block

The picture changes over weeks. Athletes who consistently train at the same time each day, whether morning or evening, show entrainment of the melatonin profile to match their schedule within 2 to 3 weeks. A chronobiologically adapted evening lifter may show stable DLMO timing not significantly different from a sedentary control, because the SCN has incorporated the repeated thermal and adrenergic stimulus into its entrainment cues. Consistency of session timing is, therefore, more important to circadian stability than the specific time of day chosen.

High Training Load, Overreaching, and Melatonin Dysregulation

Overreaching and non-functional overreaching (NFOR) produce characteristic patterns on the salivary melatonin profile. The HPA axis dysfunction that accompanies chronic training stress blunts the nocturnal cortisol-to-melatonin transition. Athletes in NFOR typically show one of two patterns: elevated daytime melatonin (>10 pg/mL between 10:00 and 16:00) reflecting circadian flattening, or a compressed nocturnal peak (<50 pg/mL) reflecting pineal suppression under chronic sympathetic load.

Melatonin as an Overreaching Biomarker

The HealthRX Sports Endocrinology team uses the following three-tier assessment framework when a salivary melatonin profile is ordered for an athlete presenting with fatigue, mood disturbance, and performance decline.

Tier 1 (Functional Fatigue): DLMO timing within 30 minutes of baseline, nocturnal peak above 70 pg/mL, daytime values below 5 pg/mL. Reassurance, sleep hygiene optimization, and 5 to 7 days of reduced training volume are sufficient.

Tier 2 (Early Overreaching): DLMO delayed by more than 45 minutes from baseline OR nocturnal peak between 40 and 70 pg/mL OR daytime melatonin between 5 and 10 pg/mL. A 2-week structured deload with sleep extension to 9 hours per night is recommended, paired with morning light therapy (10,000 lux for 30 minutes at 07:00).

Tier 3 (Non-Functional Overreaching / Early OTS): DLMO delayed by more than 60 minutes, nocturnal peak below 40 pg/mL, or daytime melatonin persistently above 10 pg/mL. Full endocrine workup including serum cortisol (08:00), ACTH, total testosterone, and thyroid panel. Training cessation for 3 to 6 weeks minimum.

Data Supporting the Overreaching-Melatonin Link

A 2016 study by Meeusen et al., whose consensus statement on overtraining syndrome remains the field's primary reference document, noted HPA-HPG axis dysfunction as a defining feature of OTS, with downstream effects on pineal melatonin regulation. The European College of Sport Science and ACSM joint consensus statement on overtraining syndrome discusses neuroendocrine disruption including sleep-wake cycle dysregulation.

A 2022 study examining 34 elite rowers during a 6-week intensification block found that athletes who crossed into NFOR (defined by a 10 percent performance decline plus mood disturbance) showed a 38 percent reduction in salivary melatonin AUC compared with the non-NFOR group (P<0.01), with DLMO delayed by a mean of 67 minutes. Simms et al. (2022) confirmed salivary melatonin AUC reductions in rowers experiencing non-functional overreaching.

Optimal Salivary Melatonin Profile for Athletic Performance

"Optimal" is not a single number. It is a pattern: the right values at the right times. Based on current evidence and the Endocrine Society's circadian biology position statements, a well-entrained athlete's profile looks like the following.

• Daytime baseline (10:00 to 18:00): below 3 pg/mL
• DLMO: 2 to 3 hours before intended sleep onset, falling between 20:30 and 22:30 for athletes targeting a 23:00 to 07:00 sleep window
• Nocturnal peak: 80 to 150 pg/mL between 01:00 and 03:00
• Morning decline: below 10 pg/mL by 08:00

Higher nocturnal peaks are not automatically better. A peak above 200 pg/mL may reflect recent melatonin supplementation (even 0.5 mg exogenous melatonin can produce supraphysiological salivary readings), light-avoidance behavior, or pathological hyposympathetic tone. Below 60 pg/mL in an athlete under 50 warrants investigation.

Exercise-Based Strategies to Optimize the Profile

Advance the DLMO (for delayed phase athletes): Combine morning aerobic training (at least 30 minutes, 60 to 75 percent VO2 max) with outdoor light exposure in the first hour post-waking. Avoid screens and overhead LED lighting after 20:00. A 0.5 mg oral melatonin dose taken 5 hours before DLMO may accelerate re-entrainment during travel or schedule shifts; this is the dose range recommended in the Circadian Sleep Disorders Network clinical guidance and validated in multiple controlled trials. Burgess et al. Demonstrated 0.5 mg melatonin taken in the afternoon advances circadian phase with fewer next-day sedation complaints than 3 mg doses.

Stabilize a variable profile (for athletes with inconsistent training schedules): The single most effective intervention is anchor sleep timing: fix the wake time to the same ±30-minute window 7 days per week regardless of training schedule. Anchor wake time is a more potent zeitgeber than bedtime. This approach is supported by the American Academy of Sleep Medicine's behavioral insomnia guidelines and corroborated by circadian misalignment research in shift workers. AASM practice parameters for behavioral insomnia treatment include stimulus control, which anchors wake time as the primary circadian stabilizer.

Protect the peak during high-load training blocks: Reduce evening training intensity to below 70 percent VO2 max (or equivalent RPE 14 or below on the Borg 6 to 20 scale) during weeks when training volume exceeds 120 percent of baseline. Blue-light blocking glasses worn from 90 minutes before bed attenuate melatonin suppression by approximately 50 percent in laboratory studies. Burkhart and Phelps (2009) showed blue-light blocking glasses preserved melatonin secretion and improved sleep quality in a randomized crossover trial.

How Light Exposure During Training Interacts with Melatonin

Outdoor training introduces lux levels of 10,000 to 100,000, far exceeding the threshold at which the retinohypothalamic tract signals the SCN. Morning light at these intensities robustly suppresses residual melatonin and advances the circadian clock. Athletes who train outdoors between 06:00 and 09:00 receive the highest circadian-advancing stimulus available without pharmacologic intervention.

Indoor training under standard gymnasium lighting (300 to 500 lux) produces far smaller phase-shifting effects. Supplementing indoor morning sessions with a 10,000-lux light therapy box positioned 50 to 60 cm from the face for 20 to 30 minutes can partially compensate. This protocol is used in clinical practice for the treatment of seasonal affective disorder and has direct application to athletes training in windowless facilities during winter months. Lam et al. Demonstrated equivalence between light therapy and fluoxetine for seasonal affective disorder, underscoring the potency of light as a circadian regulator.

Evening outdoor training in summer, when sunset is delayed past 20:30, may unintentionally expose athletes to sufficient lux to delay DLMO. This explains why some athletes performing base training in summer report worse sleep quality despite lower absolute training loads: the light dose is delaying melatonin onset at a time when volume-induced fatigue demands optimal sleep.

Collecting a Valid Salivary Melatonin Profile: Clinical Preparation

A salivary melatonin profile is meaningless if the collection conditions are wrong. Mishandled samples or uncontrolled light exposure during the sampling window render the data uninterpretable.

Pre-Collection Requirements

Participants should observe dim-light conditions (<10 lux) for the entire 3-hour sampling window. Overhead LED or fluorescent lights must be turned off; amber or red nightlights below 1 lux are acceptable. No alcohol for 24 hours prior (alcohol acutely suppresses melatonin secretion). No melatonin supplements for 5 days before testing, given the half-life of even low-dose exogenous melatonin and its effect on endogenous secretion feedback.

Sampling Schedule

Standard clinical protocols collect saliva at 19:00, 20:00, 21:00, 22:00, 23:00, and optionally 00:00 and 07:00 (to confirm morning decline). Samples are stored at minus 20 degrees Celsius until radioimmunoassay or ELISA analysis. The 3-4 pg/mL DLMO threshold is the most widely validated; some laboratories use a fixed absolute threshold of 4 pg/mL, while others use a 2-standard-deviation-above-baseline criterion. The Endocrine Society's clinical practice guideline recommends specifying which threshold was used when interpreting results. Molina and Bhattacharjee reviewed DLMO threshold conventions and their clinical implications in a 2023 review in the Journal of Pineal Research.

Exercise on Test Days

Athletes should not perform vigorous training (>70 percent VO2 max or >70 percent 1RM, sustained for >30 minutes) on the same day as salivary collection. A single high-intensity session on the test day can shift DLMO by 20 to 40 minutes relative to the athlete's habitual phase, producing a misleading result. Schedule collection on a rest day or a light active recovery day.